Abstract
The effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on head shaking behavior induced by l-5-HTP and behavioral symptoms induced with 5-methoxy-N,N,-dimethyltryptamine (5-MeODMT) in rats was evaluated. Both drugs dose-dependently reduced l-5-HTP-induced head shaking but were at least 600 times less potent than pirenperone and ketanserin and at least 50 times less potent than methysergide. ICS 205-930 and MDL 72222 were more than 1000 times less potent than pirenperone or methysergide and 100 times less potent than ketanserin in blocking 5-MeODMT-induced forepaw treading and tremor. Since it appears that head shakes induced by l-5-HTP are mediated by 5-HT2 receptors, these data suggest that ICS 205-930 and MDL 72222 do not significantly interact with 5-HT2 receptors in the brain. Furthermore, the data suggest that ICS 205-930 and MDL 72222 lack appreciable antagonistic activity at the 5-HT receptor(s) mediating those behavioral effects induced by 5-MeODMT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aghajanian GK (1981) The modulatory role of serotonin at multiple receptors in brain. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behavior. MIT Press, Cambridge, MA, pp 156–185
Bedard P, Pycock CJ (1977) “Wet dog” shake behavior in the rat: A possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16:663–670
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PBA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Colpaert FC, Janssen PAJ (1983) The head twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonistic effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. Neuropharmacology 22:993–1000
Colpaert FC, Meert TF, Niemegeers CJE, Janssen PJ (1985) Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat. Psychopharmacology 86:45–54
Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol 20:106–120
Fozard JR (1984) MDL 72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36–44
Green AR (1984) 5-HT-mediated behavior. Neuropharmacology 23:1521–1528
Jacobs BL (1976) An animal behavioral model for studying central serotonergic synapses. Life Sci 19:777–786
Janssen PAJ (1982) The pharmacology of specific, pure and potent serotonin 5-HT2 or S2-antagonists. In: Yoshida H, Hagihara Y, Ebashi S (eds) Advances in pharmacology and therapeutics, II. Biochemical immunological pharmacology. Pergamon, Oxford, pp 21–35
Leysen JE, Awouters F, Kennis L, Laudron PM, Vandenberk I, Janssen PAJ (1981) Receptor binding profile of R 41, 468, a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022
Leysen JE, Niemegeers CJE, van Neuten JM, Laudron PM (1982) (3H) Ketanserin (R-41468), a selective 3H-ligand for serotonin2 receptor binding sites. Mol Pharmacol 21:301–314
Lucki I, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists in two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther 228:133–139
Matthews WD, Smith CD (1980) Pharmacological profile of a model for central serotonin receptor activation. Life Sci 26:1397–1403
Nelson OL, Pedigo NW, Yamamura HI (1980) Multiple types of serotonin receptors. In: Yamamura HI, Olsen RW, Usdin E (eds) Psychopharmacology and biochemistry of neurotransmitter receptors. Elsevier, North Holland, Amsterdam, pp 325–338
Niemegeers CJE, Colpaert FC, Leysen JE, Awouters F, Janssen PAJ (1983) Mescaline-induced head-twitches in the rat: An invivo method to evaluate serotonin S2 antagonists. Drug Dev Res 3:123–135
Peroutka SJ, Snyder SH (1983) Multiple serotonin receptors and their physiological significance. Fed Proc 42:213–217
Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science 212:827–829
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131
Sloviter RS, Drust EG, Connor JO (1978) Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther 206:339–347
Smith LM, Peroutka S (1986) Differential effects of 5-hydroxytryptamine selective drugs on the 5-HT behavioral syndrome. Pharmacol Biochem Behav 24:1513–1519
Tricklebank MD, Forler C, Middlemiss DN, Fozard JR (1985) Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-N,N,-dimethyltryptamine in the rat. Eur J Pharmacol 117:15–24
Yap CY, Taylor DA (1983) Involvement of 5-HT2 receptors in the wet-dog shake behavior induced by 5-hydroxytryptophan in the rat. Neuropharmacology 22:801–804
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shearman, G.T., Tolcsvai, L. Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists. Psychopharmacology 92, 520–523 (1987). https://doi.org/10.1007/BF00176488
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00176488